Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study

Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups. We prospectively randomized 114 patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Arrhythmia and electrophysiology 2020-09, Vol.13 (9), p.e008531-e008531
Hauptverfasser: Pak, Hui-Nam, Park, Junbeom, Park, Je-Wook, Yang, Song-Yi, Yu, Hee Tae, Kim, Tae-Hoon, Uhm, Jae-Sun, Choi, Jong-Il, Joung, Boyoung, Lee, Moon-Hyoung, Kim, Young-Hoon, Shim, Jaemin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e008531
container_issue 9
container_start_page e008531
container_title Circulation. Arrhythmia and electrophysiology
container_volume 13
creator Pak, Hui-Nam
Park, Junbeom
Park, Je-Wook
Yang, Song-Yi
Yu, Hee Tae
Kim, Tae-Hoon
Uhm, Jae-Sun
Choi, Jong-Il
Joung, Boyoung
Lee, Moon-Hyoung
Kim, Young-Hoon
Shim, Jaemin
description Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups. We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs. After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%; =0.682; log-rank =0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%; =0.134) and cardioversion rates (5.3% versus 10.5%; =0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group ( =0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%; =0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s;
doi_str_mv 10.1161/CIRCEP.120.008531
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2430978763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2430978763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</originalsourceid><addsrcrecordid>eNptkUGP1CAYhonRuOvqD_BiOHrYjh_Q0tbb2MzqJGtsVj0TWr5x0LbMAnV3_C3-WDEdjQcPBBKe780LDyHPGawYk-xVs71pNu2KcVgBVIVgD8g5q3OWCajyh_-cz8iTEL4CSFYx-ZicCV4WhajlOfm5GbCP3vZ6oK0LEb11nr5x93Qb3KCjdRO1E23RB5tup0jXiU7wle28HU5Es9fTFzQ0Otpq7-6PYUzIf8jXdE3fz0O0fYpCf0lb78IhNbDf8ZLe6Mm40f5ISR_jbI5PyaOdHgI-O-0X5PPV5lPzLrv-8HbbrK-zXuSyyER6etnxrqr1zuS867sKUPcoGfKCsbIwOyyEKLSpECRKqEwtwKBGxqXIQVyQl0vuwbvbGUNUow09ps4Tujkonguoy6qUIqFsQftUPHjcqYO3o_ZHxUD9lqIWKSpJUYuUNPPiFD93I5q_E38sJCBfgDs3pF8J34b5Dr3aox7iXgETosxrkXHgADUAZGlBIX4BbDeabA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2430978763</pqid></control><display><type>article</type><title>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Pak, Hui-Nam ; Park, Junbeom ; Park, Je-Wook ; Yang, Song-Yi ; Yu, Hee Tae ; Kim, Tae-Hoon ; Uhm, Jae-Sun ; Choi, Jong-Il ; Joung, Boyoung ; Lee, Moon-Hyoung ; Kim, Young-Hoon ; Shim, Jaemin</creator><creatorcontrib>Pak, Hui-Nam ; Park, Junbeom ; Park, Je-Wook ; Yang, Song-Yi ; Yu, Hee Tae ; Kim, Tae-Hoon ; Uhm, Jae-Sun ; Choi, Jong-Il ; Joung, Boyoung ; Lee, Moon-Hyoung ; Kim, Young-Hoon ; Shim, Jaemin</creatorcontrib><description>Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups. We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs. After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%; =0.682; log-rank =0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%; =0.134) and cardioversion rates (5.3% versus 10.5%; =0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group ( =0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%; =0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s; &lt;0.001). In patients with persistent AF converted to paroxysmal AF by antiarrhythmic drug, the addition of POBI to CPVI did not improve the rhythm outcome of catheter ablation or influence overall safety, while leading to longer ablation time. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02176616.</description><identifier>ISSN: 1941-3084</identifier><identifier>ISSN: 1941-3149</identifier><identifier>EISSN: 1941-3084</identifier><identifier>DOI: 10.1161/CIRCEP.120.008531</identifier><identifier>PMID: 32755396</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Action Potentials ; Aged ; Anti-Arrhythmia Agents - therapeutic use ; Atrial Fibrillation - diagnosis ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - surgery ; Catheter Ablation - adverse effects ; Female ; Heart Rate - drug effects ; Humans ; Male ; Middle Aged ; Operative Time ; Prospective Studies ; Pulmonary Veins - drug effects ; Pulmonary Veins - physiopathology ; Pulmonary Veins - surgery ; Recurrence ; Risk Factors ; Seoul ; Time Factors ; Treatment Outcome</subject><ispartof>Circulation. Arrhythmia and electrophysiology, 2020-09, Vol.13 (9), p.e008531-e008531</ispartof><rights>American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</citedby><cites>FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</cites><orcidid>0000-0002-3256-3620 ; 0000-0002-1611-8172 ; 0000-0002-0261-161X ; 0000-0003-4200-3456 ; 0000-0001-6617-508X ; 0000-0001-9036-7225 ; 0000-0001-8251-1522 ; 0000-0002-4254-647X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32755396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pak, Hui-Nam</creatorcontrib><creatorcontrib>Park, Junbeom</creatorcontrib><creatorcontrib>Park, Je-Wook</creatorcontrib><creatorcontrib>Yang, Song-Yi</creatorcontrib><creatorcontrib>Yu, Hee Tae</creatorcontrib><creatorcontrib>Kim, Tae-Hoon</creatorcontrib><creatorcontrib>Uhm, Jae-Sun</creatorcontrib><creatorcontrib>Choi, Jong-Il</creatorcontrib><creatorcontrib>Joung, Boyoung</creatorcontrib><creatorcontrib>Lee, Moon-Hyoung</creatorcontrib><creatorcontrib>Kim, Young-Hoon</creatorcontrib><creatorcontrib>Shim, Jaemin</creatorcontrib><title>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</title><title>Circulation. Arrhythmia and electrophysiology</title><addtitle>Circ Arrhythm Electrophysiol</addtitle><description>Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups. We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs. After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%; =0.682; log-rank =0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%; =0.134) and cardioversion rates (5.3% versus 10.5%; =0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group ( =0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%; =0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s; &lt;0.001). In patients with persistent AF converted to paroxysmal AF by antiarrhythmic drug, the addition of POBI to CPVI did not improve the rhythm outcome of catheter ablation or influence overall safety, while leading to longer ablation time. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02176616.</description><subject>Action Potentials</subject><subject>Aged</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - surgery</subject><subject>Catheter Ablation - adverse effects</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Operative Time</subject><subject>Prospective Studies</subject><subject>Pulmonary Veins - drug effects</subject><subject>Pulmonary Veins - physiopathology</subject><subject>Pulmonary Veins - surgery</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>Seoul</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1941-3084</issn><issn>1941-3149</issn><issn>1941-3084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkUGP1CAYhonRuOvqD_BiOHrYjh_Q0tbb2MzqJGtsVj0TWr5x0LbMAnV3_C3-WDEdjQcPBBKe780LDyHPGawYk-xVs71pNu2KcVgBVIVgD8g5q3OWCajyh_-cz8iTEL4CSFYx-ZicCV4WhajlOfm5GbCP3vZ6oK0LEb11nr5x93Qb3KCjdRO1E23RB5tup0jXiU7wle28HU5Es9fTFzQ0Otpq7-6PYUzIf8jXdE3fz0O0fYpCf0lb78IhNbDf8ZLe6Mm40f5ISR_jbI5PyaOdHgI-O-0X5PPV5lPzLrv-8HbbrK-zXuSyyER6etnxrqr1zuS867sKUPcoGfKCsbIwOyyEKLSpECRKqEwtwKBGxqXIQVyQl0vuwbvbGUNUow09ps4Tujkonguoy6qUIqFsQftUPHjcqYO3o_ZHxUD9lqIWKSpJUYuUNPPiFD93I5q_E38sJCBfgDs3pF8J34b5Dr3aox7iXgETosxrkXHgADUAZGlBIX4BbDeabA</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Pak, Hui-Nam</creator><creator>Park, Junbeom</creator><creator>Park, Je-Wook</creator><creator>Yang, Song-Yi</creator><creator>Yu, Hee Tae</creator><creator>Kim, Tae-Hoon</creator><creator>Uhm, Jae-Sun</creator><creator>Choi, Jong-Il</creator><creator>Joung, Boyoung</creator><creator>Lee, Moon-Hyoung</creator><creator>Kim, Young-Hoon</creator><creator>Shim, Jaemin</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3256-3620</orcidid><orcidid>https://orcid.org/0000-0002-1611-8172</orcidid><orcidid>https://orcid.org/0000-0002-0261-161X</orcidid><orcidid>https://orcid.org/0000-0003-4200-3456</orcidid><orcidid>https://orcid.org/0000-0001-6617-508X</orcidid><orcidid>https://orcid.org/0000-0001-9036-7225</orcidid><orcidid>https://orcid.org/0000-0001-8251-1522</orcidid><orcidid>https://orcid.org/0000-0002-4254-647X</orcidid></search><sort><creationdate>20200901</creationdate><title>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</title><author>Pak, Hui-Nam ; Park, Junbeom ; Park, Je-Wook ; Yang, Song-Yi ; Yu, Hee Tae ; Kim, Tae-Hoon ; Uhm, Jae-Sun ; Choi, Jong-Il ; Joung, Boyoung ; Lee, Moon-Hyoung ; Kim, Young-Hoon ; Shim, Jaemin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Action Potentials</topic><topic>Aged</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - surgery</topic><topic>Catheter Ablation - adverse effects</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Operative Time</topic><topic>Prospective Studies</topic><topic>Pulmonary Veins - drug effects</topic><topic>Pulmonary Veins - physiopathology</topic><topic>Pulmonary Veins - surgery</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>Seoul</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pak, Hui-Nam</creatorcontrib><creatorcontrib>Park, Junbeom</creatorcontrib><creatorcontrib>Park, Je-Wook</creatorcontrib><creatorcontrib>Yang, Song-Yi</creatorcontrib><creatorcontrib>Yu, Hee Tae</creatorcontrib><creatorcontrib>Kim, Tae-Hoon</creatorcontrib><creatorcontrib>Uhm, Jae-Sun</creatorcontrib><creatorcontrib>Choi, Jong-Il</creatorcontrib><creatorcontrib>Joung, Boyoung</creatorcontrib><creatorcontrib>Lee, Moon-Hyoung</creatorcontrib><creatorcontrib>Kim, Young-Hoon</creatorcontrib><creatorcontrib>Shim, Jaemin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation. Arrhythmia and electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pak, Hui-Nam</au><au>Park, Junbeom</au><au>Park, Je-Wook</au><au>Yang, Song-Yi</au><au>Yu, Hee Tae</au><au>Kim, Tae-Hoon</au><au>Uhm, Jae-Sun</au><au>Choi, Jong-Il</au><au>Joung, Boyoung</au><au>Lee, Moon-Hyoung</au><au>Kim, Young-Hoon</au><au>Shim, Jaemin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</atitle><jtitle>Circulation. Arrhythmia and electrophysiology</jtitle><addtitle>Circ Arrhythm Electrophysiol</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>13</volume><issue>9</issue><spage>e008531</spage><epage>e008531</epage><pages>e008531-e008531</pages><issn>1941-3084</issn><issn>1941-3149</issn><eissn>1941-3084</eissn><abstract>Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups. We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs. After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%; =0.682; log-rank =0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%; =0.134) and cardioversion rates (5.3% versus 10.5%; =0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group ( =0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%; =0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s; &lt;0.001). In patients with persistent AF converted to paroxysmal AF by antiarrhythmic drug, the addition of POBI to CPVI did not improve the rhythm outcome of catheter ablation or influence overall safety, while leading to longer ablation time. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02176616.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>32755396</pmid><doi>10.1161/CIRCEP.120.008531</doi><orcidid>https://orcid.org/0000-0002-3256-3620</orcidid><orcidid>https://orcid.org/0000-0002-1611-8172</orcidid><orcidid>https://orcid.org/0000-0002-0261-161X</orcidid><orcidid>https://orcid.org/0000-0003-4200-3456</orcidid><orcidid>https://orcid.org/0000-0001-6617-508X</orcidid><orcidid>https://orcid.org/0000-0001-9036-7225</orcidid><orcidid>https://orcid.org/0000-0001-8251-1522</orcidid><orcidid>https://orcid.org/0000-0002-4254-647X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1941-3084
ispartof Circulation. Arrhythmia and electrophysiology, 2020-09, Vol.13 (9), p.e008531-e008531
issn 1941-3084
1941-3149
1941-3084
language eng
recordid cdi_proquest_miscellaneous_2430978763
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Action Potentials
Aged
Anti-Arrhythmia Agents - therapeutic use
Atrial Fibrillation - diagnosis
Atrial Fibrillation - physiopathology
Atrial Fibrillation - surgery
Catheter Ablation - adverse effects
Female
Heart Rate - drug effects
Humans
Male
Middle Aged
Operative Time
Prospective Studies
Pulmonary Veins - drug effects
Pulmonary Veins - physiopathology
Pulmonary Veins - surgery
Recurrence
Risk Factors
Seoul
Time Factors
Treatment Outcome
title Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T22%3A38%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electrical%20Posterior%20Box%20Isolation%20in%20Persistent%20Atrial%20Fibrillation%20Changed%20to%20Paroxysmal%20Atrial%20Fibrillation:%20A%20Multicenter,%20Prospective,%20Randomized%20Study&rft.jtitle=Circulation.%20Arrhythmia%20and%20electrophysiology&rft.au=Pak,%20Hui-Nam&rft.date=2020-09-01&rft.volume=13&rft.issue=9&rft.spage=e008531&rft.epage=e008531&rft.pages=e008531-e008531&rft.issn=1941-3084&rft.eissn=1941-3084&rft_id=info:doi/10.1161/CIRCEP.120.008531&rft_dat=%3Cproquest_cross%3E2430978763%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2430978763&rft_id=info:pmid/32755396&rfr_iscdi=true